Advertisement

Avatrombopag cost effective for thrombocytopenia

    • 1 Accesses

    This is a preview of subscription content, log in to check access.

    Access options

    Buy single article

    Instant unlimited access to the full article PDF.

    US$ 49.95

    Price includes VAT for USA

    Subscribe to journal

    Immediate online access to all issues from 2019. Subscription will auto renew annually.

    US$ 214

    This is the net price. Taxes to be calculated in checkout.

    Reference

    1. Allen LF, et al. Cost-Effectiveness of Avatrombopag for the Treatment of Thrombocytopenia in Patients with Chronic Liver Disease. 61st Annual Meeting and Exposition of the American Society of Hematology : abstr. 3454, 7 Dec 2019. Available from: URL: https://ash.confex.com/ash/2019/webprogram/Paper131822.html

    Download references

    Rights and permissions

    Reprints and Permissions

    About this article

    Verify currency and authenticity via CrossMark

    Cite this article

    Avatrombopag cost effective for thrombocytopenia. PharmacoEcon Outcomes News 844, 6 (2020). https://doi.org/10.1007/s40274-020-6469-2

    Download citation